AstraZeneca and Amgen’s Tezspire succeeds in 澳洲10体彩开幸运直播官网 168澳洲幸运十开奖历史查询结果趋势 澳洲幸运10正规网 澳洲十开奖官网历史 Phase III nasal polyps trial
The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with nasal polyps.
Reeves’ 2024 budget promises life sciences investment
Pharma companies must adapt to keep pace with AI developments, say experts
Luna Diabetes trials automated wearable insulin pump
Nordic and BeeKeeperAI partner to accelerate AI clinical support systems